CoChat

Amyloid β-Protein (Aβ) 1–40 But Not Aβ1–42 Contributes to the Experimental Formation of Alzheimer Disease Amyloid Fibrils in Rat Brain

Open access
Shin, Ryong-Woon, Ogino, Koichi, Kondo, Akira, Saido, Takaomi C., Trojanowski, John Q., Kitamoto, Tetsuyuki, Tateishi, Jun · 1997 · The Journal of Neuroscience
Cited by 97

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Two major C-terminal variants ending at Val40 and Ala42 constitute the majority of amyloid β-protein (Aβ), which undergoes postsecretory aggregation and deposition in the Alzheimer disease (AD) brain. To probe the differential pathobiology of the two Aβ variants, we used an in vivo paradigm in which freshly solubilized Aβ1–40 or Aβ1–42 was injected into rat brains, followed by examination using Congo red birefringence, Aβ immunohistochemistry, and electron microscopy. In the rat brain, soluble Aβ 1–40 and Aβ1–42 formed aggregates, and the Aβ1–40 but not the Aβ1–42 aggregates showed Congo red birefringence. Electron microscopy revealed that the Aβ1–40 aggregates contained fibrillar structures similar to the amyloid fibrils of AD, whereas the Aβ1–42 aggregates contained nonfibrillar amorphous material. Preincubation of Aβ1–42 solution in vitro led to the formation of birefringent aggregates, and after injection of the preincubated Aβ1–42, the aggregates remained birefringent in the rat brain. Thus, a factor or factors might exist in the rat brain that inhibit the fibrillar assembly of soluble Aβ1–42. To analyze the postsecretory processing of Aβ, we used the same in vivo paradigm and showed that Aβ1–40 and Aβ1–42 were processed at their N termini to yield variants starting at pyroglutamate, and at their C termini to yield variants ending at Val40 and at Val39. Thus the normal rat brain could produce enzymes that mediate the conversion of Aβ 1–40/1–42 into processed variants similar to those in AD. This experimental paradigm may facilitate efforts to elucidate mechanisms of Aβ deposition evolving into amyloid plaques in AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.17-21-08187.1997

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 97

Metadata

Authors
Shin, R.-W., Ogino, K., Kondo, A., Saido, T. C., Trojanowski, J. Q., Kitamoto, T., & Tateishi, J.
Venue
The Journal of Neuroscience
Published
1997-11-01
Volume
17
Issue
21
Pages
8187-8193
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W1782560356
Cited by
97
References
18
FWCI
2.87
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid β-Protein (Aβ) 1–40 But Not Aβ1–42 Contributes to the Experimental Formation of Alzheimer Disease Amyloid Fibrils in Rat Brain. https://app.cochat.ai/papers/10.1523/jneurosci.17-21-08187.1997
The paper
Shin, R.-W., Ogino, K., Kondo, A., Saido, T. C., Trojanowski, J. Q., Kitamoto, T., & Tateishi, J. (1997). Amyloid β-Protein (Aβ) 1–40 But Not Aβ1–42 Contributes to the Experimental Formation of Alzheimer Disease Amyloid Fibrils in Rat Brain. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.17-21-08187.1997

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.